Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SK Square Americas is the U.S.-based investment arm of SK Square, a South Korean portfolio management and investment company focused primarily on semiconductors, ICT, AI, and other frontier technologies. The entity operates as a private corporate investment vehicle headquartered in New York and is described by SK as focusing on early-stage ventures. Public materials indicate that its remit spans future technologies including AI, blockchain/digital assets, media, and healthcare, but it does not appear to be an operating biotech, pharma, or healthcare product company itself. Instead, it functions as a strategic investor within the broader SK ecosystem, which includes interests in semiconductors, technology platforms, and selected life science and bioscience investments. For a biotech analyst, the key point is that SK Square Americas is best classified as an investment arm with some healthcare investing exposure rather than as a drug developer or healthcare operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SK Square Americas.